Geistlich Pharma
Martin Wartmann currently serves as Group General Counsel and Chief Compliance Officer at Geistlich Pharma AG since April 2022. Wartmann has extensive experience in legal roles, having held positions such as Group General Counsel and Company Secretary at Satisloh and Selecta, where responsibilities included managing legal departments, providing corporate and business law advice, and leading strategic disposals and acquisitions. Prior to these roles, Wartmann practiced as an Attorney at Law and Civil Law Notary at FRORIEP, offering legal counsel to various clients. An academic background includes degrees from the University of St. Gallen (EMBA), California Western School of Law (LL.M.), and the University of Lucerne (lic.iur.).
This person is not in the org chart
This person is not in any offices
Geistlich Pharma
1 followers
Geistlich Pharma AG develops, produces and distributes medical devices and drugs (anti-infectives, vitamins) for regenerative medicine at the Wolhusen and Root sites in central Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its three business units Geistlich Biomaterials, Geistlich Surgery and Geistlich Medical have ten subsidiaries and global distribution. Some 500 employees work for the company around the world. The company is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas